| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |